CMW client AXIM Biotechnology was featured in an LA Weekly article about the launch of their new nutrastical product, CanChew Plus.
CanChew Plus features cannabidiol or CBD, an active ingredient in cannabis that reportedly has shown promise for treating epileptic seizures, inflammation and psychosis. CanChew gets its CBD from industrial hemp.
“This is not coming from marijuana,” the gum’s lead scientist, Dr. George E. Anastassov, says. “This has very little or no THC — 11 parts per million. It definitely will not get anybody high, even if you take 10 at once.”
Read the Full Article HERE
